Navigation Links
Multiple Sclerosis Association of America's MRI Institute Marks 10 Years of Helping Individuals with Multiple Sclerosis Obtain MRIs
Date:6/26/2012

CHERRY HILL, N.J., June 26, 2012 /PRNewswire/ -- The Multiple Sclerosis Association of America (MSAA) is proud to mark the 10-year anniversary of one of its most sought after programs — the MRI Institute. This program is designed to help people who have been diagnosed with multiple sclerosis (MS) and lack health insurance coverage, acquire an MRI scan. The Institute has been supported by the pharmaceutical companies EMD Serono, Inc. and Pfizer Inc since 2002. During that time, the Institute has helped over 7,500 individuals who have MS and could not otherwise afford an MRI to monitor their multiple sclerosis.

(Logo:  http://photos.prnewswire.com/prnh/20120620/PH27981LOGO )

According to MSAA client Emily Johnson, the MSAA MRI Institute assisted in providing a much-needed resource in managing her MS. "As a young person with relapsing-remitting MS, my expenses associated with my MS, especially medication and medical procedures, such as an MRI are often a burden," states Johnson. "I was so excited to learn that the MSAA MRI Institute could possibly help me obtain a needed MRI. The assistance provided meant one less concern for me. I am truly grateful for the MSAA MRI Institute."

MRI scans play an essential role in the management of the ever-changing course of multiple sclerosis. With the valuable information provided by an MRI, physicians are able to make better treatment decisions and monitor the effectiveness of prescribed treatments making adjustments as necessary. Unfortunately, many people have neither the necessary insurance coverage nor the financial means to acquire an MRI to evaluate the status of their illness. The MSAA MRI Institute was established to meet this important need.

"Today, the MRI is recognized as one of our most powerful tools to gauge the effectiveness of therapy and monitor the progress of the disease," explains MSAA Chief Operating Officer Robert Rapp. "MSAA is proud to have been able to help so many individuals who would have been unable to receive the vital information provided by an MRI due to a lack of adequate insurance."

The MRI Institute is available for individuals in the United States with a confirmed diagnosis of multiple sclerosis and must meet eligibility requirements. To participate in the MRI Institute, documentation of financial need and a written request from a physician for an MRI is required. The MRI Institute applications are available by calling MSAA at (800) 532-7667, extension 120 and can be found on MSAA's website, www.msassociation.org/mri  

The Multiple Sclerosis Association of America (MSAA) is a national, nonprofit organization dedicated to enriching the quality of life for everyone affected by multiple sclerosis. MSAA provides vital programs and services, such as: a toll-free Helpline; informative publications including a magazine, The Motivator; website featuring educational videos and research updates; S.E.A.R.C.H.™ program to assist the MS community with learning about different treatment choices; equipment distribution ranging from grab bars to wheelchairs; cooling accessories for heat-sensitive individuals; a mobile phone app, My MS Manager; educational events and activities; MRI funding and insurance advocacy; and more. For additional information, please visit www.msassociation.org or call (800) 532-7667.

The most common neurological disorder diagnosed in young adults, multiple sclerosis is an autoimmune disease of the central nervous system. This disorder damages or destroys the protective covering (known as myelin) surrounding the nerves, causing reduced communication between the brain and nerve pathways. Common symptoms include visual problems, overwhelming fatigue, difficulty with balance and coordination, and various levels of impaired mobility. MS is not contagious or fatal.


'/>"/>
SOURCE Multiple Sclerosis Association of America
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
2. Roskamp Institute Reports Beneficial Effects of Nutritional Supplementation with Anatabine in an Animal Model of Multiple Sclerosis
3. Aushon to Launch New Multiplex Immunoassay Platform
4. Webcast Alert: Isis Pharmaceuticals Hosts Dr. Sotirios Tsimikas to Review KYNAMRO™ data Presented at the European Atherosclerosis Society 2012 Meeting
5. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
6. Bayer Employees Named Rising Stars by Healthcare Businesswomens Association
7. Washington State Medical Association (WSMA) Urges Adults to Get Recommended Immunizations
8. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
9. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
10. Percutaneous Tibial Nerve Stimulation Included in the American Urological Associations Overactive Bladder Clinical Treatment Guidelines
11. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... new report "Global Anti-Bacterial Drugs Market Assessment & Forecast: 2015 - ... the North America continued to lead global ... translated into revenues worth US$ 16,907.3 million. ... Asia-Pacific , Latin America , ... anti-bacterial market is inclined towards North America ...
(Date:2/8/2016)... -- Respiratory Devices - Medical Devices Pipeline Assessment, ... report, " Respiratory Devices - Medical Devices Pipeline ... Devices currently in pipeline stage. The report ... comparative analysis of the products at various stages ... in the pipeline product development. It also provides ...
(Date:2/8/2016)... and FAIRFIELD, N.J. , Feb. 8, ... Pharmaceuticals, Inc. (Medimetriks) today announced that they have entered ... commercialization rights for OPA-15406 in the U.S. and ... manufacturing rights.  OPA-15406 is a topical, non-steroidal phosphodiesterase IV ... --> --> In ...
Breaking Medicine Technology:
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... ... Techniques.” The guide will ensure lab personnel have a basic understanding of the ... lab measurement protocols. Enhanced understanding will help them reduce waste and rework to ...
(Date:2/9/2016)... California (PRWEB) , ... February 09, 2016 , ... i2i ... one of the highest preliminary data vendors in the latest KLAS report, Population Health ... i2i has led the developing market for population health management (PHM). The latest ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... with BASF Human Nutrition into the Food & Beverage and ... been BASF’s channel partner throughout Canada and USA geographies east of the Rocky ...
(Date:2/8/2016)... ... February 08, 2016 , ... Brenton Engineering , powered ... and flow wrapped products at WestPack 2015, February 9-11, in Anaheim, California. This ... to semi-automatic or fully-automatic case packing with a small footprint, rugged, highly flexible, ...
(Date:2/8/2016)... ... 08, 2016 , ... Local insurance agency Dennis Fuller & ... has initiated a fundraiser for a two year old little girl named Bella, ... To support this beautiful child who is facing life’s journey without her loving ...
Breaking Medicine News(10 mins):